Fluorescence Diagnostics of Basal Cell Carcinomas Comparing Methyl-aminolaevulinate and Aminolaevulinic Acid and Correlation with Visual Clinical Tumour Size
DOI:
https://doi.org/10.2340/00015555-1068Keywords:
aminolaevulinic acid, fluorescence diagnostics, fluorescence contrast, methyl-aminolevulinate, PDT, photodynamic therapy.Abstract
Fluorescence diagnostics based on aminolaevulinic acid (ALA) fluorescence has been suggested as an in vivo pre-surgical tool for tumour demarcation. We performed fluorescence diagnostics of 35 basal cell carcinomas (BCCs) undergoing photodynamic therapy (PDT) using methylaminolaevulinate (MAL). In addition, a semi-automated thresholding algorithm was implemented to detect the potential tumour region. The mean tumour fluorescence contrast was found to be 1.65±0.06 during the first MAL-PDT session, and increased to 1.84±0.07 at the second treatment (p < 0.01). This could imply that disruption of the skin barrier and inflammatory responses after the first session of PDT led to higher accumulation of protoporphyrin IX during the second session of PDT. The tumour areas detected based on fluorescence in small BCCs (< 1 cm2) were in general (n = 18/23) larger than the visual clinical tumour size. In addition, the fluorescence contrast using MAL (1.65±0.06) was found to be significantly higher (p<10–4) than the contrast (data from previous study) after application of ALA (1.20±0.06). Thus, MAL generally provides higher tumour contrast than ALA in BCCs, and should be preferred for use in fluorescence diagnostics. Correlation between fluorescence, lack of treatment response and/or pain was not observed.Downloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Carin Sandberg, John Paoli, Martin Gillstedt, Christina B. Halldin, Olle Larkö, Ann-Marie Wennberg, Marica B. Ericson
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.